News for ViewRay, Inc. (6L9.F)

Published at

Mar 5, 2021 10:01 PM

by prnewswire.com

neutral

neutral

ViewRay To Participate in the 21st Annual Oppenheimer Healthcare Conference

/PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) (the "Company") today announced that members of management will be participating in the 21st Annual Oppenheimer...

6L9.SG 6L9.MU 6L9.F

Read more →
Published at

Mar 5, 2021 3:36 AM

by seekingalpha.com

neutral

neutral

ViewRay, Inc. (VRAY) CEO Scott Drake on Q4 2020 Results - Earnings Call Transcript

ViewRay, Inc. (NASDAQ:VRAY) Q4 2020 Earnings Conference Call March 04, 2021 04:30 PM ET Company Participants Michaella Gallina - Head, Investor Relations Scott Drake - President & Chief...

VRAY 6L9.MU 6L9.F

Read more →
Published at

Mar 4, 2021 11:43 PM

by seekingalpha.com

neutral

neutral

ViewRay, Inc. 2020 Q4 - Results - Earnings Call Presentation (NASDAQ:VRAY)

The following slide deck was published by ViewRay, Inc.

VRAY 6L9.SG 6L9.MU 6L9.F

Read more →
Published at

Jan 22, 2021 4:15 PM

by benzinga.com

mixed

mixed

Mid-Morning Market Update: Markets Open Lower; Schlumberger Tops Q4 Estimates

Following the market opening Friday, the Dow traded down 0.55% to 31,004.75 while the NASDAQ fell 0.08% to 13,519.54. The S&P also fell, dropping 0.32% ...

SLBN.MX SLB.PA SLB SCL.SG SCL.MU SCL.F SCL.BE OBLN MNTK MKR.JO IZEA 2IZ.F 24OA.F 24OA.BE VRAY BWEN 9IRA.SG 9IRA.F 9IRA.BE 6L9.SG 6L9.MU 6L9.F

Read more →
Published at

Jan 22, 2021 7:42 AM

by markets.businessinsider.com

mixed

mixed

Elekta divests its stake in ViewRay

STOCKHOLM, Jan. 22, 2021 /PRNewswire/ -- Elekta AB (EKTA-B.ST) announced today that it has sold its 7.3 percent of the outstanding common stock (1...

VRAY 6L9.SG 6L9.MU 6L9.F EKTAF EJXB.SG EJXB.MU EJXB.F EJXB.BE

Read more →
Published at

Jan 22, 2021 7:40 AM

by yahoo.com

positive

positive

Elekta divests its stake in ViewRay

Elekta AB (EKTA-B.ST) announced today that it has sold its 7.3 percent of the outstanding common stock (11,501,597 shares) in ViewRay, Inc. (Nasdaq:VRAY). Elekta has no remaining shares in ViewRay after the transaction.

VRAY AZRX 6L9.SG 6L9.MU 6L9.F

Read more →
Published at

Jan 22, 2021 7:40 AM

by prnewswire.com

positive

positive

Elekta divests its stake in ViewRay

/PRNewswire/ -- Elekta AB (EKTA-B.ST) announced today that it has sold its 7.3 percent of the outstanding common stock (11,501,597 shares) in ViewRay, Inc....

VRAY EKTAF EJXB.SG EJXB.MU EJXB.F EJXB.BE 6L9.SG 6L9.MU 6L9.F

Read more →
Published at

Jan 22, 2021 7:40 AM

by markets.businessinsider.com

mixed

mixed

Elekta divests its stake in ViewRay

STOCKHOLM, Jan. 22, 2021 /PRNewswire/ -- Elekta AB (EKTA-B.ST) announced today that it has sold its 7.3 percent of the outstanding common stock (1...

VRAY 6L9.SG 6L9.MU 6L9.F EKTAF EJXB.SG EJXB.MU EJXB.F EJXB.BE

Read more →
Published at

Jan 8, 2021 6:28 AM

by rttnews.com

mixed

mixed

ALDX Catches Eye, RVNC Faces Busy Year Ahead, SRPT Plunges On DMD Trial Data

Today's Daily Dose brings you news about Alnylam's transthyretin-mediated (ATTR) amyloidosis trial results; Sarepta's mixed results of investigational gene therapy SRP-9001 in patients with Duchenne muscular dystrophy; Aldeyra's dry eye disease trial results; and Revance's anticipated milestones.

DUL.MU DUL.F DUL.DE ALNY AB3A.SG AB3A.MU AB3A.F AB3A.BE VRAY UAVP.SG UAVP.MU UAVP.F UAVP.BE SRPT RVNC RTI.F OGEN ALDX ADXN.SW 6L9.SG 6L9.MU 6L9.F 137.F 137.BE

Read more →
Published at

Jan 5, 2021 12:01 PM

by rttnews.com

mixed

mixed

Pre-market Movers In Healthcare Sector: CHEK, SYN, NSPR, ZOM, BNGO, VRAY...

What's moving these stocks in pre-market hours today?.

ZOM OCGN NOVN JAGX BNGO.MX BNGO 6LU.F 6LU.BE 2Y3.MU 2Y3.BE 2H51.F 2H51.BE 1JA2.SG 1JA2.F 1JA2.BE ZSAN VRAY SYN NSPR LIFE CHEK 471A.F 471A.BE 0ZPN.SG 0ZPN.F 0ZPN.BE SFYC.F SFYC.BE ALRN 7CC.F 7CC.BE 6L9.SG 6L9.MU 6L9.F 015.F 015.BE

Read more →
Published at

Jan 5, 2021 6:51 AM

by markets.businessinsider.com

mixed

mixed

CALA Falls As CANTATA Trial Fails, Haven Healthcare To Be Disbanded, MTNB Awaits MAT9001 Data In Q1

(RTTNews) - Today's Daily Dose brings you news about Pandion's phase Ia trial of autoimmune disease drug PT101 in healthy volunteers; Matinas BioP...

PAND OCGN AMRN 2H51.F 2H51.BE VRAY PRVB JAGX 6L9.SG 6L9.MU 6L9.F 2VB.MU 2VB.F 2VB.BE 1JA2.SG 1JA2.F 1JA2.BE MGNX M55.F M55.BE LLY CALA BNGO.MX BNGO 2Y3.MU 2Y3.BE 2CB.F 2CB.BE

Read more →
Published at

Jan 5, 2021 6:51 AM

by rttnews.com

mixed

mixed

CALA Falls As CANTATA Trial Fails, Haven Healthcare To Be Disbanded, MTNB Awaits MAT9001 Data In Q1

Today's Daily Dose brings you news about Pandion's phase Ia trial of autoimmune disease drug PT101 in healthy volunteers; Matinas BioPharma's anticipated milestone for this quarter; Calithera's disappointing results from phase II study of Telaglenastat in patients with renal cell carcinoma, Provention Bio's near-term regulatory catalyst; and disbanding of Haven Healthcare joint venture.

PAND OCGN AMRN 2H51.F 2H51.BE VRAY PRVB JAGX 6L9.SG 6L9.MU 6L9.F 2VB.MU 2VB.F 2VB.BE 1JA2.SG 1JA2.F 1JA2.BE MGNX M55.F M55.BE LLY CALA BNGO.MX BNGO 2Y3.MU 2Y3.BE 2CB.F 2CB.BE

Read more →